| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 1,099 | 0 | 1,099 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| BRISTOL MYERS SQUIBB | 4,496,510 | 9,235,800 |
| FATE THERAPEUTICS | 342,796 | 56,100 |
| FIBROGEN INC | 1,019,649 | 26,589 |
| GERON CORP | 59,000 | 42,200 |
| HELIX ENERGY SOLUTIONS | 94,028 | 950,900 |
| NEUROCRINE BIOSCIENCES | 5,887,440 | 16,865,280 |
| VOYAGER THERAPEUTICS | 90,778 | 126,600 |
| AMICUS THERAPEUTICS INC | 745,436 | 851,400 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FEDERAL TAX PAYMENT | 15,457 | 0 | 0 |